- Home
- PGHL vs ABEO Comparison
PGHL vs ABEO Comparison
Compare PGHL & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGHL
- ABEO
- Stock Information
- Founded
- PGHL 2018
- ABEO N/A
- Country
- PGHL Hong Kong
- ABEO United States
- Employees
- PGHL N/A
- ABEO N/A
- Industry
- PGHL
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- PGHL
- ABEO Health Care
- Exchange
- PGHL NYSE
- ABEO Nasdaq
- Market Cap
- PGHL 294.2M
- ABEO 243.9M
- IPO Year
- PGHL 2024
- ABEO 1980
- Fundamental
- Price
- PGHL $1.14
- ABEO $5.19
- Analyst Decision
- PGHL
- ABEO Strong Buy
- Analyst Count
- PGHL 0
- ABEO 3
- Target Price
- PGHL N/A
- ABEO $18.00
- AVG Volume (30 Days)
- PGHL 1.3M
- ABEO 251.8K
- Earning Date
- PGHL 08-12-2024
- ABEO 11-14-2024
- Dividend Yield
- PGHL N/A
- ABEO N/A
- EPS Growth
- PGHL N/A
- ABEO N/A
- EPS
- PGHL 0.05
- ABEO N/A
- Revenue
- PGHL $13,464,430.00
- ABEO N/A
- Revenue This Year
- PGHL N/A
- ABEO N/A
- Revenue Next Year
- PGHL N/A
- ABEO $15,721.96
- P/E Ratio
- PGHL $22.89
- ABEO N/A
- Revenue Growth
- PGHL 20.83
- ABEO 147.52
- 52 Week Low
- PGHL $1.03
- ABEO $3.05
- 52 Week High
- PGHL $107.36
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- PGHL N/A
- ABEO 34.35
- Support Level
- PGHL N/A
- ABEO $5.05
- Resistance Level
- PGHL N/A
- ABEO $5.66
- Average True Range (ATR)
- PGHL 0.00
- ABEO 0.27
- MACD
- PGHL 0.00
- ABEO -0.06
- Stochastic Oscillator
- PGHL 0.00
- ABEO 13.21
About PGHL PRIMEGA GROUP HOLDINGS LIMITED
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.